OREANDA-NEWS. Biofrontera (FSE / AIM: B8F), the specialist for sun induced skin cancer, has this week launched the third product of its derma-cosmetic line Belixos®, a cooling and cleaning day care gel designed for situations of increased sebum production.

Belixos® Gel was developed for the special needs of inflamed, reddened skin prone to impurities, the ideal basic care for rosacea and acne. To minimize the risk for sensitive reactions and skin irritations the gel formulation was reduced to just a few high-value ingredients. The formulation causes a cooling sensation and combines the extracts of cinnamon bark in the Sepicontrol A5 complex and mahonia aquifolium with Biofrontera's innovative Biocolloid technology.

The extract of mahonia relieves inflammation, redness and itching, typical signs of rosacea. The active ingredient complex Sepicontrol A5 with cinnamon bark has antibacterial activity and removes callused skin, regulates sebum and clears congested sebaceous glands.

As with the other products in the Belixos®  dermo-cosmetic series in cream and liquid formulations, the underlying biocolloid technology causes an optimized penetration of this unique ingredient combination from traditional medicinal plants extracts.

Commenting, Prof. Dr. Hermann L?bbert, CEO of Biofrontera, said: "The new Belixos® Gel compliments the Company's existing derma-cosmetic products which successfully bring together the benefits of natural ingredients, already recognized for their efficacy, and Biofrontera's innovative biocolloid formulation, effectively delivering excellent cosmetic properties to the skin."